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Introduction
Rest tremor is a hallmark of Parkinson’s disease (PD), 
yet its pathogenesis is incompletely understood. A spe-
cific pattern of neuronal loss in the substantia nigra in 
PD patients with tremor has been described [38–40, 53], 
but does not translate into a different pattern of striatal 
dopamine deficiency or postsynaptic dopamine recep-
tor density compared to akinetic-rigid PD [19, 25, 51]. 
Nigro-striatal dopamine deficiency correlates best with 
bradykinesia, but not with tremor [65]. Oscillating neu-
rons in one or multiple localizations within the basal 
ganglia-thalamo-cortical loop may cause rest tremor, 
and an active contribution of the cerebellum and the 
cerebello-thalamo-cortical projections has been postu-
lated [16, 42, 61].
Clinical manifestation and disease progression are 
variable and highlight the heterogeneity of PD. The clin-
ical heterogeneity reflects the extent and topography of 
the pathological process and may indicate different 
causes of PD as also suggested by specific phenotypic 
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■ Abstract  Background Rest 
tremor is a hallmark of Parkinson’s 
disease (PD), but its pathogenesis 
remains incompletely understood. 
Nigro-striatal dopamine deficiency 
correlates best with bradykinesia, 
but not with tremor. Oscillating 
neurons in one or multiple local-
izations within the basal ganglia-
thalamo-cortical loop may cause 
rest tremor, and an active contribu-
tion of the cerebellum and the cer-
ebello-thalamo-cortical projections 
has been postulated. Objective To 
compare the pattern of grey matter 
volume in PD patients with and 
without tremor to identify struc-
tural correlates of rest tremor. 
Methods Voxel-based morphome-
try (VBM) of a high-resolution 3 
Tesla, T1-weighted MR images, 
 pre-processed according to an opti-
mized protocol using SPM2, was 
performed in 24 patients with mild 
to moderate PD comparing local 
grey matter volume in patients 
with (n = 14) and without rest 
tremor (n = 10). Results Grey  matter 
volume is decreased in the right 
quadrangular lobe and declive of 
the cerebellum in PD with tremor 
compared to those without 
(PFDR < 0.05). Conclusions These 
 results demonstrate for the first 
time morphological changes in the 
cerebellum in PD patients with rest 
tremor and highlight the involve-
ment of the cerebellum and cere-
bello-thalamo-cortical circuit in 
the pathogenesis of parkinsonian 
rest tremor. 
■ Key words  Parkinson’s disease · 
voxel-based morphometry · tremor 
akinetic-rigid syndrome
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presentations of patients with defined genetic forms of 
PD. Approaches to classify PD into subgroups have prin-
cipally been based on the clinical phenomenology, in 
particular, discriminating tremor-dominant, akineto-
rigid and also “mixed” PD. Clinical evidence suggests 
that the motor phenotype may be predictive of clinical 
course and prognosis [21]. Compared to patients with 
tremor-dominant PD, “akinetic-rigid” patients show a 
more rapid clinical progression and have an increased 
risk to develop disability [27, 30, 31, 33, 35, 48] and de-
mentia [1]. 
Brain imaging may allow identification of anatomical 
correlates of phenotypic differences such as a distinct 
pattern of grey matter loss in PD patients with and with-
out tremor. MRI-based voxel-based morphometry 
(VBM) offers an operator-independent, unbiased and 
comprehensive morphological analysis of the brain. 
VBM has shown more widespread loss of grey matter in 
PD with dementia (PDD) [8, 9, 50, 56, 62]. VBM may also 
allow to distinguish PD from atypical Parkinsonian dis-
orders [7, 55]. 
We intended to study the differences in the pattern of 
grey matter volume in PD patients with and without 
tremor to identify possible structural correlates of rest 
tremor, and also to test the hypothesis of a more ad-
vanced cortical grey matter loss in PD patients without 
tremor. 
Methodology
■ Study population
Patients with idiopathic PD were prospectively re-
cruited in the Department of Neurology, University 
Hospital of Zurich, Switzerland. Inclusion criteria were 
mild to moderate PD corresponding to Hoehn and Yahr 
stages (HY) 2–3 [33]. Diagnosis of PD was based on UK 
PD Brain Bank criteria [26] with a minimum disease 
duration of three years. We chose to investigate only 
men of a certain age span of 55–70 years due to sex and 
age differences in brain size [13, 29]. Exclusion criteria 
were advanced PD stages equivalent to HY 4–5, second-
ary parkinsonism, atypical parkinsonian diseases and 
other concomitant neurodegenerative diseases, tremor 
of non-parkinsonian origin, dementia as defined by a 
score < 24 in the Mini-Mental State Examination [20], 
any structural pathology in brain MR and CT imaging 
except for mild vascular changes within age norms, pre-
vious stereotactic surgery, and medical or psychiatric 
 conditions precluding study participation and/or per-
formance of MRI. Patients were dichotomized in a 
group with and without tremor. Patients with tremor 
were required to have classical parkinsonian rest tremor 
with or without postural or action tremor of similar 
frequency, and in PD patients without tremor, rest as 
well as postural or action tremor must have been ex-
cluded, also by meticulous review of all medical docu-
ments. 
All patients gave written informed consent and the 
local ethics committee had approved the study.
■ Study protocol
All patients underwent a detailed clinical assessment in-
cluding history, physical and neurological examination, 
and neuropsychological and -psychiatric evaluation to 
control for any differences between PD patients with 
and those without tremor which could confound mor-
phological analysis. We presumed that a distinct pattern 
of grey matter volume distribution related to tremor 
would show up when comparing patient groups with 
similar clinical deficits except for tremor as their corre-
sponding grey matter volume changes would match. For 
this reason, a comparison of PD patients with healthy 
controls would have been confounded and was, there-
fore, not performed. 
All patients were examined on medication and in the 
“off” condition when medication effect was wearing off 
or during an (unpredictable) “off”. A practically “de-
fined off” condition, which would have required a tem-
porary withdrawal of dopaminergic and also anti-cho-
linergic medication was not undertaken. To assess the 
severity of rest tremor with and without postural or ac-
tion tremor more accurately considering its variability, 
an additional composite tremor score was based on clin-
ical and historical data of the last 6 months using a sim-
ilar scale as in UPDRS (0 = absent; 1 = mild and infre-
quent, not bothersome; 2 = moderate and bothersome; 
3 = severe and interfering with many activities and 
4 = marked and interfering with most activities). 
Detailed neuropsychological evaluation included 
Mini-Mental State Examination [20], verbal and figural 
(five-point test) fluency, Rey Auditory Verbal Learning 
Test (RAVLT), Visual Design Learning Test (RVDLT) and 
Complex Figure Test, Stroop Interference Test [60], 
Goldenberg Association Learning [28] and screening for 
other cognitive deficits such as apraxia, aphasia and ag-
nosia. A handedness questionnaire [12] was applied. Pa-
tients were also screened for hallucinations, delusions 
and other psychiatric disorders, and evaluated by a psy-
chiatrist if deemed necessary. Depression was consid-
ered present if either one or both cut-offs of 14/15 [66] 
and 12/13 [17] in the Beck Depression Inventory (BDI) 
[4] and the Hamilton Depression Rating Scale (HAMD) 
[32], respectively, was/were exceeded. 
Medical records including history and examination, 
and anatomical and, if performed nuclear brain imaging 
were reviewed. 
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■ Statistical analysis
Statistical analysis of clinical data was carried out with 
SPSS Version 12.0.1 for Windows. Normality of distribu-
tion was checked with skewness and kurtosis tests. Un-
paired t-tests were used to compare parametric data 
between groups, and Mann-Whitney U test for non-
parametric data. Chi-square tests or Fisher exact test 
were used to compare nominal data. 
■ Brain MR scanning procedure 
MR imaging using a standard head coil was performed 
at a 3T MR-scanner (PHILIPS, Achieva). For T1-weighted 
high resolution structural MRI, a T1-weighted, 3D-MP-
RAGE sequence technique (TR = 8.7 ms, TE 2.3 ms, flip 
angle 8.0°, voxel-size 0.86 × 0.86 × 1.0 mm, axial slice ori-
entation, matrix size 256 × 256) covering the anterior 
and posterior commissure within the same trans-axial 
plane was acquired in each patient. Images were re-
viewed for motion artifacts before pre-processing and 
redone if deemed necessary. 
■ Voxel-based morphometry 
Image pre-processing followed the optimized protocol 
as described by Good et al. [29] using SPM2 (http://www.
fil.ion.ucl.ac.uk/spm): first an automatic segmentation 
was performed using age-matched template and priors 
(mean age: 56.6 ± 18.6), second the deformation field 
was determined by normalization of the segmented gray 
and white matter image using the respective prior, third 
the initial image was normalized using the determined 
deformation field followed by an automatic segmenta-
tion of the normalized image again using age-matched 
template and priors. Finally, in order to preserve the to-
tal amount of brain tissue, grey and white matter voxel 
values were multiplied by the Jacobian determinants de-
rived from the spatial normalization step, respectively 
[29].
For comparison of the two groups of patients with 
and without tremor, a voxel-wise ANCOVA of these 
maps was performed. To compensate for effects result-
ing from general brain atrophy, a measure for the rela-
tive total brain volume Vbrain = (Vgrey matter + Vwhite matter)/
Vliquor was included as nuisance variable into the statisti-
cal model. Two orthogonal contrasts: patients with ver-
sus without tremor and patients without versus with 
tremor were calculated (puncorrected < 0.001) to test for re-
gions of lower amount of grey matter volume within the 
non tremor group (CT-NT) and tremor group (CNT-T) 
group, respectively. 
Additional voxel-wise ANCOVAs were performed to 
test for effects of impaired balance and fluctuations, re-
spectively, by comparing groups of patients with and 
without impaired balance and groups of patients with 
and without fluctuations as well as a regression analysis 
using the UPDRS III Balance and Gait score as explana-
tory variable to exclude possible confounding effects of 
clinical differences between patients with and those 
without tremor.
Based on current understanding of tremor pathogen-
esis [16, 42, 61], we predicted structural changes in the 
basal ganglia, the thalamus, the brainstem and/or the 
cerebellum (RBG-thalamus-brainstem-cerebellum), and, therefore, 
restricted the statistical analysis to these regions apply-
ing a mask of these regions to the grey matter volume 
distribution maps prior to statistical analysis. 
To control for additional differences outside these re-
gions, a second statistical analysis was performed re-
stricted to the cerebral cortex (RCerebrum). Data were cor-
rected for multiple comparisons across the respective 
region using the false-discovery rate (FDR) method 
[24].
Results
All patients with PD seen in the Department of Neurol-
ogy in the years 2002–2004 were screened, and 24 of 27 
men who qualified for the study could be included. Two 
had declined participation and one could not be in-
cluded due to MR-incompatibility (pacemaker). Four-
teen of the 24 (58 %) had classical parkinsonian rest 
tremor including four who fulfilled criteria of tremor-
dominant PD [36, 67] and ten who could be considered 
“mixed” PD. In the ten remaining PD patients without 
tremor, rest tremor as well as postural and/or action 
tremor was firmly excluded. PD diagnosis was con-
firmed and ET excluded in all patients in a follow-up 
assessment > 2 years (in 2007) after enrollment in this 
study.
Demographic and clinical characteristics are shown 
in Table 1. Motor complications and impaired balance 
were more prevalent in patients without tremor, who 
had a higher score of balance and gait (UPDRS items 
27–30). No other differences were found, neither in 
scores of bradykinesia (items 18–19, 23–26, 31), rigidity 
(items 22), single and combined UPDRS parts (I, II, III 
on and IV; sparse III “off” data precluded comparison), 
nor in regard to the degree of asymmetry and to the lat-
erality of disease preponderance. 
Rest tremor was bilateral in ten and unilateral in four 
patients (right, n = 3; UPDRS item 20 on, median 2, range 
0–10). Ten of those fourteen had an additional postural 
and/or action tremor at a similar frequency range as the 
ipsilateral rest tremor (bilateral, n = 8; unilateral right, 
n = 2; UPDRS item 21 on, median 1.5, range 0–3), which 
lessened transiently during action and re-emerged dur-
ing posture after a delay of some seconds corresponding 
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to postural and action tremor related to PD [37]. Pos-
tural and/or action tremor was milder and less persis-
tent than rest tremor in all patients and none had an 
isolated postural and/or action tremor. Concomitant es-
sential tremor was excluded in all. Composite rest ± pos-
tural and/or action tremor scores were similar in most 
patients when off medication (moderate, n = 6; severe, 
n = 7; marked, n = 1). The response of rest tremor and 
also of postural and/or action tremor to dopaminergic 
(in all) and anti-cholinergic (n = 3) medication was 
moderate to good. Rest with and without action and/or 
postural tremor in the best “on” condition was either 
mild (n = 7) or even absent (n = 4), but remained moder-
ate and bothersome in three without interfering in daily 
activities. Neurological examination was otherwise nor-
mal in all patients. 
Compared to age- and sex-matched healthy controls 
(unpublished data), neuropsychological assessment of 
the patients yielded mild impairments in executive 
functions (figural fluency, and concept learning and 
shifting) and in memory (verbal and figural learning 
and recall). No significant differences in the neuropsy-
chological test results were found when comparing pa-
tients with and those without tremor. Depression was 
prevalent in both groups, but a short neuro-psychiatric 
screening did not identify significant psychiatric co-
morbidities requiring further evaluation or therapeutic 
intervention. Four (two with tremor) reported single 
episodes of visual hallucinations, but no confusion or 
delusions. All patients were right-handed.
■ Voxel-based morphometry
Within the region RBG-thalamus-brainstem-cerebellum at a level of 
statistical significant puncorrected < 0.001, the contrast CTN-T 
revealed a lower amount of grey matter volume for the 
tremor group in the posterior part of the cerebellar 
quadrangular lobe mainly right, but also paramedian on 
the left side, and in the declive of the vermis (Table 2). 
The contrast CT-NT revealed a small cluster of lower 
amount of grey matter volume for the non-tremor group 
along the lateral border of the right thalamus (Table 2).
Within the region RCerebrum, four clusters of higher 
amount of grey matter volume were found for the con-
trast CT-NT (Table 2) located in the medial anterior tem-
poral lobes (right: Brodmann area [BA] 38, 34 and 28; 
left: BA 28), the left middle frontal gyrus and the right 
inferior frontal gyrus (BA 9). The contrast CTN-T revealed 
in total three small clusters of reduced grey matter vol-
ume, located in the right frontal and parietal lobe (Ta-
ble 2).
At statistical significance level pFDR < 0.05, only the 
cluster within the posterior part of the right quadrangu-
lar lobe and the declive of the cerebellum was significant 
(Fig. 1).
No significant clusters of grey matter volume changes 
(pFDR < 0.05) were found neither for the region BG-thal-
amus-brainstem-cerebellum nor the region Cerebrum in 
the additional analysis of the groups with and without 
impaired balance, the groups with and without fluctua-
tions and the regression analysis of the UPDRS III Bal-
ance and Gait score.
Tremor (n = 14) No tremor (n = 10)
P
Age [years; mean ± SD]  61.5 ± 3.5   62.3 ± 5.1 nsa
Age at onset [years; mean ± SD]  53.1 ± 6   55 ± 7.6 nsb
Hoehn-Yahr stages [median (range)]   2.3 (2–3)    2.5 (2.5–3) nsb
Disease duration [years; median (range)]   6 (3–20)    7.5 (3–18.5) nsb
Duration of therapy [years; median (range)]   6 (3–18)    6 (2.3–18.5) nsb
LED [mg; median (range)] 980 (150–1790) 1140 (100–1540) nsb
Motor score (UPDRS III) [score; median (range)]  25 (12–35)   28 (12–35) nsb
Impaired balance (HY ≥ 2.5)c [% (n)]  50 % (7)  100 % (10) 0.008d
Balance and Gait (UPDRS items 27–30)   3.4 ± 1.5    4.5 ± 0.9 0.041b
Motor complicationse [% (n)]  21.4 % (3)   80 % (8) 0.005d
MMSE [score; mean ± SD]  28.6 ± 1.2   28.0 ± 0.8 nsa
PDQ39 [score; median (range)]  35 (9–86)   53 (9–90) nsb
Depression (Beck/Hamilton) [% (n)]  42.9 % (6)   40 % (4) nsd
LED Levodopa equivalent dosage; ns statistically non-significant; PDQ 39 Parkinson’s Disease Questionnaire (39 
items); SD standard deviation; UPDRS III Unified Parkinson’s Disease Rating Scale, part III (motor score)
a independent t-Test; b Mann-Whitney U-Test; c Patients with impaired balance have an increased prevalence of 
motor fluctuations (64.7 % vs 0 %, p = 0.004) and decreased prevalence of tremor (35.3 % vs 100 %, p = 0.004); 
d Pearson χ2-Test; e Patients with motor complications have a longer duration of disease (median 108, 60–240 
months vs 60, 36–156 months; p = 0.005) and of dopaminergic therapy (median 104, 58–222 months vs 60, 
27–144 months; p = 0.015) with higher LED (median 1355, 570–1540 mg vs 900, 100–1790 mg; p = 0.01) and 
younger age at onset (50.3 ± 5.9 vs 56.9 ± 5.7 years, p = 0.011)
Table 1  Demographic and clinical findings of 
patients with Parkinson’s disease with and without 
tremor
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Fig. 1  The cerebellar region of lower amount of grey matter for the tremor group in comparison to the non-tremor group is shown. At a significance level corrected for false 
positive clusters due to multiple testing PFDR < 0.05, this region is located in the posterior part of the right quadrangular lobe and the declive (A). Without this correction at 
puncorrected < 0.001, this region extends over the midline to a small part in the contralateral left quadrangular lobe (B)
Table 2  Clusters of different grey matter volume for the two brain regions and the two different contrasts at a significance level puncorrected < 0.001 and in bold at a 
significance level pFDR < 0.05 corrected for false positive clusters due to multiple testing. Anatomical structure, size of the cluster and coordinates of local maxima of 
significance are given
Clusters of different grey matter volume within RBG-thalamus-brainstem-cerebellum
Contrast CT-NT Contrast CNT-T
Anatomical structure Nvoxel Local maxima 
of significance 
(Tal. coord.)
Anatomical structure Nvoxel Local maxima
of significance
(Tal. coord.)
x y z x y z
lateral border of right thalamus 110 25 –24 9 Right and left posterior part 
of the quadrangular lobe and 
declive
3529
25
21
–4
–67
–64
–65
–22
–19
–19
Clusters of different grey matter volume within RCerebrum
Contrast CT-NT Contrast CNT-T
Anatomical structure Nvoxel Local maxima 
of significance 
(Tal. coord.)
Anatomical structure Nvoxel Local maxima
of significance
(Tal. coord.)
x y z x y z
Right medial anterior temporal 
lobe (BA 28, 34 and 38)
3375 28
23
23
14
34
13
2
4
1
16
–38
–26
–41
–19
–39
Right parietal lobe (BA 39) 324 48 –65 27
Right middle frontal gyrus (BA 10) 222 50 –51 29
Right postcentral gyrus (BA 1) 548 55 –18 50
Left medial anterior temporal 
lobe (BA 28)
304 –19 1 –24
Left middle frontal 
gyrus (BA 5)
565 –21 –12 42
Right inferior frontal 
gyrus (BA 8)
273 37 5 26
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Discussion
The principal finding of this study is a reduction of the 
grey matter volume in the right quadrangular lobe and 
declive of the cerebellum in PD patients with rest tremor 
compared to PD patients without tremor. This prospec-
tive study using high-resolution MRI VBM to compare 
brain morphology of the different motor phenotypes of 
PD demonstrates for the first time a structural abnor-
mality in the cerebellum in PD with rest tremor and 
highlights the postulated cerebellar involvement in the 
pathogenesis of rest tremor [16, 42, 61]. Rest tremor has 
been shown to correlate with increased metabolic [3, 15, 
22] and oscillatory activity [64] in the cerebellum, thala-
mus and motor cortex. Those structures are connected 
by somatotopically organized cerebello-thalamo-corti-
cal projections, and the posterior quadrangular lobule 
(lobule VI) of the cerebellar cortex has been shown to be 
linked with the hand area of the motor cortex [43]. This 
finding underscores previously reported grey matter 
volume changes in the ventral intermediate nucleus 
(Vim) in the lateral thalamus which relays the cerebel-
lum with the motor cortex [42]. The grey matter volume 
change in our study bordering the lateral thalamus 
lacked statistical significance and also its small size pre-
cludes further interpretation. 
A strong argument in favor of a contribution of the 
cerebellum and its projections to the thalamus in the 
pathogenesis of rest tremor comes from experience with 
stereotactic surgery. The thalamic targets, Vim [5, 10, 44, 
46, 47] and the cerebello-thalamic projections [11], have 
proven efficacious in the suppression of rest tremor and 
Vim was even postulated to a better target than the ven-
tro-oralis posterior nucleus (Vop) receiving pallidal af-
ferents [61]. The fact that Vim receives cerebellar affer-
ents, but none from the basal ganglia [34], implies that 
rest tremor originates from either a cerebellar generator 
[61] or an interaction of the basal ganglia- and cerebello-
thalamo-cortical circuits in the cerebral cortex, where 
those segregated circuits converge [16]. 
In monkeys, ablation of the interpositus nucleus 
manifests with tremor during reaching movements [63]. 
This nucleus receives projections from the intermediate 
zone of the cerebellum where the decrease of grey mat-
ter volume is mainly found in our patients with tremor. 
The intermediate zone and its output via the interposi-
tus nucleus have been postulated to modulate the activ-
ity of agonist and antagonist muscles during movements 
[63], and also to control whether the muscle activity pat-
tern is reciprocal or a co-contraction [58]. 
A possible explanation for the preponderance of the 
findings in the right cerebellum may be the disparity of 
tremor manifestation. All patients with tremor but one 
had tremor on the right, while three had no tremor on 
the left. Brain asymmetry due to lateralization [2, 23] 
and consistent right-handedness of all patients may 
have also contributed to the asymmetry of findings. A 
structural asymmetry of the cerebellar hemispheres in 
association with handedness has been described, and 
seems to be more marked in right-handers [59]. On the 
contrary, the equal-handedness may have minimized a 
confounding effect of brain asymmetry. 
These grey matter volume changes in VBM raise 
questions about their nature. In PD, α-synuclein aggre-
gates in cerebellar glia [54] and Purkinje cells [49] have 
been shown, but their appearance in regard to disease 
stage and clinical correlate remain yet to be identified. 
The decrease of grey matter volume may reflect a loss of 
neurons and/or glial cells, but also changes on the syn-
aptic or cellular level [18]. 
Also, large clusters of decreased grey matter volume 
are found in the right medial anterior temporal lobe and 
to a lesser degree in left homologous counterpart in pa-
tients without tremor. These are the cortical regions 
which become earliest affected in the disease process 
after the brainstem nuclei [6], which is in line with the 
notion that “akinetic-rigid” patients without tremor ex-
perience a more rapid clinical progression to disability 
[27, 30, 31, 33, 35, 48] and dementia [1]. However, clusters 
in these regions have not reached significance after cor-
rection. A longitudinal analysis may provide more evi-
dence to this preliminary observation.
Shortcomings of this study may be the available spa-
tial resolution of MRI precluding the differentiation of 
small neuronal structures, particularly in the brainstem 
and thalamus. Changes in thalamic grey matter may 
have been missed, but the other VBM study had com-
pared PD patients with unilateral rest tremor with 
healthy subjects [42]. Confounding factors had been 
minimized by exclusion of advanced PD, dementia and 
other co-morbidities. Both groups had a similar demo-
graphic, clinical and neuropsychological profile, except 
for more prevalent balance impairment, and motor fluc-
tuations and dyskinesias in the patients without tremor. 
These differences are not expected to have confounded 
our findings since no morphological correlates of either 
balance impairment or motor fluctuations and dyskine-
sias were identified in additional VBM analyses, motor 
fluctuations and dyskinesias presumably originate from 
long-lasting functional alterations without known struc-
tural abnormality, and impaired balance and eventually 
loss of postural stability in PD is primarily caused by 
degeneration of brainstem nuclei such as the tegmental 
pedunculopontine nucleus [45, 52, 57]. Essential tremor 
which could be a confounding factor, even though a re-
cent VBM study had failed to detect cerebellar changes 
in essential tremor [14], was clinically excluded. Postural 
and action tremor related to PD differs from essential 
tremor and is considered a continuation of rest tremor 
during action and posture presumably originating from 
the same tremor generator [37]. 
For the study objectives, we dichotomized patients 
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based on the presence of tremor alone ensuring that all 
patients with tremor and, therefore, a presumed under-
lying tremor generator were included. The deviating 
tremor-dominant PD criteria [36, 67] may allow the 
identification of a subgroup of patients with a compara-
tively benign disease course [27, 30, 31, 33, 35, 41, 48], but 
the small number of tremor-dominant PD patients in 
this collective precludes a separate VBM analysis of this 
subgroup. 
In line with physiological and functional imaging 
studies, this study provides good evidence of a struc-
tural substrate for the involvement of the cerebellum in 
the pathogenesis of rest tremor.
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